Newsletter logo   Search News     Daily News   

Published:

Holzer Holzer & Fistel, LLC Announces Investigation Into KV Pharmaceutical Company

ATLANTA, Nov. 20, 2008 (GLOBE NEWSWIRE) -- Holzer Holzer & Fistel, LLC is investigating possible violations of the federal securities laws by KV Pharmaceutical Company ("KV" or the "Company") . The investigation focuses on allegations that the Company did not disclose potential violations of federal regulations and FDA guidelines.

Shareholders who purchased KV common stock between February 15, 2008 and November 12, 2008 with questions concerning their legal rights are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel, Jr., Esq. or Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832.

Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.

CONTACT:  Holzer Holzer & Fistel, LLC
          Michael I. Fistel, Jr., Esq.
            mfistel@holzerlaw.com
          Marshall P. Dees, Esq.
            mdees@holzerlaw.com
          (888) 508-6832 (toll-free)
          1117 Perimeter Center West, Suite E-107
          Atlanta, GA  30338
Tags: ,FinancialServices,LAW,LEGAL,Law&, LegalIssues,NYSE0001

  care2 logo  digg logo  
 


Be Interviewed today

Editorial Cartoons
Political Cartoons

newsletter logo
Get Chitika Premium



Sponsor Links:

Writers Wanted
Help NewsBlaze provide daily news, including top stories, Home and Garden, Technology, The Environment and more. NewsBlaze Writer
Relevant Sites:
NewsBlaze 
Copyright © 2004-2009 NewsBlaze LLC
Use of this website is subject to our Terms of Service and Privacy Policy       Support    Press Room